TY - JOUR
T1 - What does it mean to be affiliated with care?
T2 - Delphi consensus on the definition of “unaffiliation” and “specialist” in sickle cell disease
AU - the Sickle Cell Disease Implementation Consortium
AU - Lamont, Andrea E.
AU - Hsu, Lewis L.
AU - Jacobs, Sara
AU - Gibson, Robert
AU - Treadwell, Marsha
AU - Chen, Yumei
AU - Lottenberg, Richard
AU - Axelrod, Kathleen
AU - Varughese, Taniya
AU - Melvin, Cathy
AU - Smith, Sharon
AU - Chukwudozie, Ifeanyi Beverly
AU - Kanter, Julie
AU - Hankins, Jane
AU - Carroll, Yvonne
AU - Klesges, Lisa
AU - Khan, Hamda
AU - Smeltzer, Matthew
AU - Nwosu, Chinonyelum
AU - Gurney, James
AU - Potter, Jerlym
AU - Alberts, Nicole
AU - Frey, Jeffrey
AU - Jackson, Michael
AU - Badawy, Sherif
AU - DeBaun, Michael
AU - Homayouni, Ramin
AU - Shamrin, Tamanna
AU - Kang, Guolian
AU - Estepp, Jeremie
AU - Vichinsky, Elliott
AU - Wun, Ted
AU - Potter, Michael
AU - Hagar, Ward
AU - Marsh, Anne
AU - Neumayr, Lynne
AU - Phillips, Shannon
AU - Adams, Robert
AU - Mueller, Martina
AU - Shah, Nirmish
AU - Tanabe, Paula
AU - Bosworth, Hayden
AU - Jackson, George
AU - Johnson, Fred
AU - Richesson, Rachel
AU - Kutlar, Abdullah
AU - Snyder, Angela
AU - Fernandez, Maria
AU - Lyon, Matthew
AU - Pace, Betty
AU - Clay, E. Leila Jerome
AU - Lawrence, Raymona
AU - Richardson, Lynne D.
AU - Glassberg, Jeffrey
AU - Simon, Jena
AU - Genes, Nicholas G.
AU - Loo, George T.
AU - Shapiro, Jason S.
AU - Souffront, Kimberly
AU - Clesca, Cindy
AU - Linton, Elizabeth
AU - Ryan, Gery
AU - Gordeuk, Victor
AU - Gutierrez, Melissa
AU - Hirschtick, Jana
AU - Krishnan, Jerry
AU - Sebro, Nadew
AU - Wandersman, Abe
AU - Berbaum, Michael
AU - Bobba, Kishore
AU - Colla, Joe
AU - Erwin, Kim
AU - Lamont, Andrea
AU - Martin, Molly
AU - Pandit, Ananta
AU - Saving, Kay
AU - Shannon, Robin
AU - Winn, Robert
AU - Zun, Leslie
AU - Nocek, Judith
AU - King, Allison
AU - Baumann, Ana
AU - Calhoun, Ce Ce
AU - Luo, Lingzi
AU - James, Aimee
AU - Abel, Regina A.
AU - Kroner, Barbara L.
AU - Hendershot, Tabitha
AU - DiMartino, Lisa
AU - Battestilli, Whitney
AU - Brambilla, Don
AU - Preiss, Liliana
AU - Pugh, Norma
AU - Thompson, Alexis A.
AU - Tonkins, William
N1 - Publisher Copyright:
© This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
PY - 2022/11
Y1 - 2022/11
N2 - Accruing evidence reveals best practices for how to help individuals living with Sickle Cell Disease (SCD); yet, the implementation of these evidence-based practices in healthcare settings is lacking. The Sickle Cell Disease Implementation Consortium (SCDIC) is a national consortium that uses implementation science to identify and address barriers to care in SCD. The SCDIC seeks to understand how and why patients become unaffiliated from care and determine strategies to identify and connect patients to care. A challenge, however, is the lack of agreed-upon definition for what it means to be unaffiliated and what it means to be a “SCD expert provider”. In this study, we conducted a Delphi process to obtain expert consensus on what it means to be an “unaffiliated patient” with SCD and to define an “SCD specialist, ” as no standard definition is available. Twenty-eight SCD experts participated in three rounds of questions. Consensus was defined as 80% or more of respondents agreeing. Experts reached consensus that an individual with SCD who is unaffiliated from care is “someone who has not been seen by a sickle cell specialist in at least a year.” A sickle cell specialist was defined as someone with knowledge and experience in SCD. Having “knowledge” means: being knowledgeable of the 2014 NIH Guidelines, “Evidence-Based Management of SCD”, trained in hydroxyurea management and transfusions, trained on screening for organ damage in SCD, trained in pain management and on SCD emergencies, and is aware of psychosocial and cognitive issues in SCD. Experiences that are expected of a SCD specialist include experience working with SCD patients, mentored by a SCD specialist, regular attendance at SCD conferences, and obtains continuing medical education on SCD every 2 years.” The results have strong implications for future research, practice, and policy related to SCD by helping to lay a foundation for an new area of research (e.g., to identify subpopulations of unaffiliation and targeted interventions) and policies that support reaffiliation and increase accessibility to quality care.
AB - Accruing evidence reveals best practices for how to help individuals living with Sickle Cell Disease (SCD); yet, the implementation of these evidence-based practices in healthcare settings is lacking. The Sickle Cell Disease Implementation Consortium (SCDIC) is a national consortium that uses implementation science to identify and address barriers to care in SCD. The SCDIC seeks to understand how and why patients become unaffiliated from care and determine strategies to identify and connect patients to care. A challenge, however, is the lack of agreed-upon definition for what it means to be unaffiliated and what it means to be a “SCD expert provider”. In this study, we conducted a Delphi process to obtain expert consensus on what it means to be an “unaffiliated patient” with SCD and to define an “SCD specialist, ” as no standard definition is available. Twenty-eight SCD experts participated in three rounds of questions. Consensus was defined as 80% or more of respondents agreeing. Experts reached consensus that an individual with SCD who is unaffiliated from care is “someone who has not been seen by a sickle cell specialist in at least a year.” A sickle cell specialist was defined as someone with knowledge and experience in SCD. Having “knowledge” means: being knowledgeable of the 2014 NIH Guidelines, “Evidence-Based Management of SCD”, trained in hydroxyurea management and transfusions, trained on screening for organ damage in SCD, trained in pain management and on SCD emergencies, and is aware of psychosocial and cognitive issues in SCD. Experiences that are expected of a SCD specialist include experience working with SCD patients, mentored by a SCD specialist, regular attendance at SCD conferences, and obtains continuing medical education on SCD every 2 years.” The results have strong implications for future research, practice, and policy related to SCD by helping to lay a foundation for an new area of research (e.g., to identify subpopulations of unaffiliation and targeted interventions) and policies that support reaffiliation and increase accessibility to quality care.
UR - http://www.scopus.com/inward/record.url?scp=85141894132&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0272204
DO - 10.1371/journal.pone.0272204
M3 - Article
C2 - 36367870
AN - SCOPUS:85141894132
SN - 1932-6203
VL - 17
JO - PloS one
JF - PloS one
IS - 11 November
M1 - e0272204
ER -